Fasiplon

Fasiplon
Clinical data

ATC code	none
Identifiers
IUPAC name 6-Ethyl-7-methoxy-5-methyl-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-imidazo[1,2-a]pyrimidine
CAS Number	106100-65-6^Y
PubChem CID	208954
ChemSpider	181047^N
UNII	XCA050IPGB
ChEMBL	CHEMBL62735^N
Chemical and physical data
Formula	C₁₃H₁₅N₅O₂
Molar mass	273.290 g/mol
3D model (Jmol)	Interactive image
SMILES CC1=NC(C2=CN3C(N=C(OC)C(CC)=C3C)=N2)=NO1
InChI InChI=1S/C13H15N5O2/c1-5-9-7(2)18-6-10(11-14-8(3)20-17-11)15-13(18)16-12(9)19-4/h6H,5H2,1-4H3^N Key:MEBYKPLMXIRYRQ-UHFFFAOYSA-N^N
^NY (what is this?)

Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.

Fasiplon binds strongly to benzodiazepine sites on the GABA_A receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action. It was developed by a team at Roussel Uclaf in the 1990s